Borderline Personality Disorder
Conditions
Keywords
mindfulness
Brief summary
This study explores the feasibility of a mindfulness-based intervention for people with a diagnosis of borderline personality disorder.
Detailed description
This is an uncontrolled feasibility trial of an eight-week mindfulness-based intervention for people with a diagnosis of borderline personality disorder. A battery of measures will be administered at baseline, in a time window of six to zero weeks prior to the start of the intervention. Outcome measures will be repeated in the two weeks after the end of the eight-week intervention, along with a qualitative interview.
Interventions
A version of mindfulness-based cognitive therapy that has been adapted for people with a diagnosis of borderline personality disorder. This comprises eight weekly session, each lasting ninety minutes.
Sponsors
Study design
Eligibility
Inclusion criteria
* Are on the caseload of a United Kingdom National Health Service Assessment and Treatment Service in the recruitment area and have had contact with that service in the past three months * Have received the diagnosis of Borderline Personality Disorder from a suitably qualified health care professional, and continue to meet criteria for this diagnosis according to the SCID-II (Structured Clinical Interview for DSM Disorders Version II) at their screening assessment * Have sufficient English language speaking and comprehension abilities to access group discussions and hand-out materials * Have not previously engaged in a mindfulness-based intervention. As in other similar trials, a minimum dose has been operationally defined as having undertaken 50% or more of a mindfulness-based intervention delivered face-to-face by a suitably qualified health care professional * Are not currently receiving, nor have plans to receive any other form of psychological therapy during the course of the study
Exclusion criteria
* Have psychosis * Misuse alcohol or drug to a level that requiring detox * Have a intellectual disability * Present a high level of risk requiring inpatient management at the time of their screening assessment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Participant retention in percent | At post-intervention (i.e. 8 weeks after the start of the intervention). | The number of participants who remain in the study at the post-intervention time point divided by the number of participants who are recruited into the study at baseline, expressed as a percentage |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline at post-intervention in the Patient Health Questionnaire (PQH-9). | Post-intervention (i.e. 8 weeks after the start of the intervention) | — |
| Change from baseline at post-intervention in the Generalized Anxiety Disorder Scale (GAD-7) | Post-intervention (i.e. 8 weeks after the start of the intervention) | — |
| Change from baseline at post-intervention in the Five-Facet Mindfulness Questionnaire (FFMQ) | Post-intervention (i.e. 8 weeks after the start of the intervention) | — |
| Change from baseline at post-intervention in the Difficulties in the Emotion Regulation Scale (DERS) | Post-intervention (i.e. 8 weeks after the start of the intervention) | — |
| Elliot et al.'s (2001) Change Interview. | Post-intervention (i.e. 8 weeks after the start of the intervention) | — |
| Recruitment rate | Baseline | The number of participants recruited into the study at baseline divided by the time taken to recruit these participants, measured from the date at which recruitment opened. |
| Qualitative feedback from participants on intervention acceptability in response to questions 6 and 7 of Elliot et al.'s (2001) Change Interview | Post-intervention (i.e. 8 weeks after the start of the intervention) | — |
| United Kingdom National Health Service Friends and Family Test (FFT). | Post-intervention (i.e. 8 weeks after the start of the intervention) | — |
Countries
United Kingdom